ENGOT-en9/LEAP-001: A phase III, randomized, active-controlled, open-label study of pembrolizumab plus lenvatinib versus paclitaxel plus carboplatin for newly diagnosed advanced or recurrent endometrial cancer

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2020-10, Vol.159, p.221-221
Main Authors: Marth, C., Vulsteke, C., Rubio, M.J.R., Makker, V., Braicu, E.I., McNeish, I.A., Madry, R., Ayhan, A., Hasegawa, K., Wu, X., Dutta, L., Xu, C., Keefe, S., Lee, J., Pignata, S.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2020.05.366